Global Cardiopulmonary Devices Market is projected to witness a decent growth rate of 5% by 2026

BRUSSELS - July 20, 2022 - PRLog -- Cardiopulmonary diseases includes a range of medical conditions that affect the heart and lungs. Cardiopulmonary devices include heart-lung machines (HLM), percutaneous ventricular assist devices (PVAD), extracorporeal membrane oxygenation (ECMO) & Autotransfusion (ATS). These devices find application in cardiac surgeries, pulmonary surgeries, congenital defects, cardiopulmonary bypass procedures, cardiogenic shock/respiratory failure, joint replacement surgeries, aneurysm surgeries, transplants, and other indications.

Adverse Impact of Covid-19 on the Cardiopulmonary Devices Market

During 2020-2021, most of the patients infected with the Covid-19 virus showcased moderate symptoms and recovered quickly. However, some patients developed severe respiratory failure and required intensive care unit (ICU) admission and mechanical ventilation. To treat and save the lives of these severe Covid-19 patients, ECMO emerged as a promising treatment option. The ECMO machine supports both the heart and lungs and stabilizes patients to allow their bodies more time to fight the virus.

Rising awareness about ECMO, HLM & other cardiopulmonary devices and the implementation of new ECMO centers during the COVID-19 pandemic further boosted the growth of the global cardiopulmonary devices market.

Regulatory Policies in Major Markets Fuels the Cardiopulmonary Devices Market

To fight the Covid-19 pandemic and to offer cardiopulmonary and advanced circulatory support products and therapies that may benefit Covid-19 virus-infected patients, in April 2020 the FDA permitted manufacturers of cardiopulmonary bypass devices to modify the product indications for use to include ECMO therapy for greater than six hours, without prior submission of a premarket notification to FDA. The favourable regulatory policy change resulted in increased sales of cardiopulmonary and advanced circulatory support products.

Efficient Growth Strategies Adopted by Industry Players to Establish Their Foothold in Cardiopulmonary Devices Market

The global cardiopulmonary devices market is marked by the presence of both established and emerging players. Players operating in the market have adopted both organic and inorganic growth strategies such as acquisitions, and new product launches to garner higher market share.

The global cardiopulmonary devices market is poised to grow at a decent rate in the upcoming years due to increasing cases of cardiopulmonary cases, technological advancements in cardiopulmonary devices, growing number of orthopaedic & transplant procedures, and rising aging population.

Competitive Landscape Analysis: Cardiopulmonary Devices Market

The global cardiopulmonary devices market is marked by the presence of major market players such as LivaNova, Getinge, Terumo, Medtronic, Abbott, Abiomed, Haemonetics, Fresenius, among others.

Get Customized Research Report on Cardiopulmonary Devices Market @ https://meditechinsights.com/cardiopulmonary-devices-market/